[Development of human embryonic stem cell platforms for human health-safety evaluation].

Autor: Yu GY; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China., Cao T; Faculty of Dentistry Research Laboratories,National University of Singapore, Singapore 119083,Singapore., Zou XH; Centre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou 310058, China., Zhang XH; Department of Dental Materials, Peking University School and Hospital of Stomatology, Beijing 100081, China., Fu X; Research Center of Plastic Surgery Hospital, Chinese Academy of Medical Science, Beijing 100144, China., Peng SQ; Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing 100071, China., Deng XL; Department of Geriatric Dentistry, Peking University School and Hospital of Stomatology, Beijing 100081, China., Li SL; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China., Liu H; Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology, Beijing 100081, China., Xiao R; Research Center of Plastic Surgery Hospital, Chinese Academy of Medical Science, Beijing 100144, China., Ouyang HW; Centre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou 310058, China., Peng H; Third Clinical Division, Peking University School and Hospital of Stomatology, Beijing 100081, China., Chen X; Centre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou 310058, China., Zhao ZM; Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing 100071, China., Wang XY; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China., Fang HQ; Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing 100071, China., Lu L; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China., Ren YL; Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology, Beijing 100081, China., Xu MM; Department of Geriatric Dentistry, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Jazyk: čínština
Zdroj: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences [Beijing Da Xue Xue Bao Yi Xue Ban] 2016 Feb 18; Vol. 48 (1), pp. 1-4.
Abstrakt: The human embryonic stem cells (hESCs) serve as a self-renewable, genetically-healthy, pluripotent and single source of all body cells, tissues and organs. Therefore, it is considered as the good standard for all human stem cells by US, Europe and international authorities. In this study, the standard and healthy human mesenchymal progenitors, ligament tissues, cardiomyocytes, keratinocytes, primary neurons, fibroblasts, and salivary serous cells were differentiated from hESCs. The human cellular health-safety of NaF, retinoic acid, 5-fluorouracil, dexamethasone, penicillin G, adriamycin, lead acetate PbAc, bisphenol A-biglycidyl methacrylate (Bis-GMA) were evaluated selectively on the standardized platforms of hESCs, hESCs-derived cardiomyocytes, keratinocytes, primary neurons, and fibroblasts. The evaluations were compared with those on the currently most adopted cellular platforms. Particularly, the sensitivity difference of PM2.5 toxicity on standardized and healthy hESCs derived fibroblasts, currently adopted immortalized human bronchial epithelial cells Beas-2B and human umbilical vein endothelial cells (HUVECs) were evaluated. The RESULTS showed that the standardized hESCs cellular platforms provided more sensitivity and accuracy for human cellular health-safety evaluation.
Databáze: MEDLINE